price
PT
AMEX · PTN
Palatin Technologies, Inc.
Healthcare · Biotechnology
$10.00
Up+$0.53 (+5.60%)
Updated Aug 14, 2026, 2:49 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 641.56M
- P/E ratio
- -4.99
- Dividend yield
- 0.00%
- 52-week range
- $7.21 – $23.78
- Volume
- 44.4K
- Avg. volume
- 1.78M
Price performance
PTN price history
1M range · 21 trading sessions · Daily adjusted prices
PTN closed at $10.00 after 21 trading sessions, up 17.99% for the selected period.
- Last close
- $10.00
- Period change
- +17.99%
- Period low
- $7.36
- Period high
- $10.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $9.50 | $10.93 | $9.50 | $10.00 | 44.4K |
| Aug 12, 2026 | $7.6274 | $9.58 | $7.2701 | $9.47 | 180.24K |
| Aug 11, 2026 | $7.74 | $7.74 | $7.3701 | $7.41 | 6.92K |
| Aug 10, 2026 | $7.76 | $8.20 | $7.28 | $7.36 | 12.81K |
| Aug 7, 2026 | $8.30 | $8.30 | $7.451 | $7.77 | 18.28K |
| Aug 6, 2026 | $8.35 | $8.3999 | $7.61 | $7.8701 | 4.4K |
| Aug 5, 2026 | $8.34 | $8.5082 | $7.60 | $7.94 | 8.1K |
| Aug 4, 2026 | $8.4261 | $8.4261 | $7.90 | $8.01 | 11.05K |
| Aug 3, 2026 | $7.925 | $8.30 | $7.8301 | $8.23 | 12.19K |
| Jul 31, 2026 | $8.20 | $8.20 | $7.58 | $7.70 | 5.85K |
| Jul 30, 2026 | $8.18 | $8.57 | $7.49 | $7.81 | 14.1K |
| Jul 29, 2026 | $8.01 | $8.5052 | $7.61 | $8.08 | 8.49K |
| Jul 28, 2026 | $8.09 | $8.165 | $7.21 | $7.68 | 6.81K |
| Jul 27, 2026 | $7.72 | $8.3087 | $7.72 | $7.81 | 13.35K |
| Jul 24, 2026 | $8.17 | $8.245 | $7.54 | $7.7052 | 8.62K |
| Jul 23, 2026 | $8.01 | $8.36 | $8.00 | $8.0346 | 5.5K |
| Jul 22, 2026 | $8.51 | $8.51 | $8.10 | $8.15 | 5.14K |
| Jul 21, 2026 | $8.69 | $8.77 | $8.47 | $8.62 | 6.1K |
| Jul 20, 2026 | $8.95 | $8.95 | $8.47 | $8.48 | 11.33K |
| Jul 17, 2026 | $8.59 | $9.09 | $8.04 | $9.09 | 23.49K |
| Jul 16, 2026 | $9.515 | $9.79 | $8.26 | $8.475 | 11.59K |
Latest PTN news
The latest Smart Investors Daily articles mentioning PTN.
Stock researchResearch & News · SEC Filings
Loading stock research…